Abstract:Background: Deep brain stimulation (DBS) is a typical intervention treating drug-refractory dystonia. Currently, the selection of the better target, the GPi or STN, is debatable. The outcomes of DBS treating dystonia classified by body distribution and etiology is also a popular question. Objective: To comprehensively compare the efficacy, quality of life, mood, and adverse effects (AEs) of GPi-DBS vs. STN-DBS in dystonia as well as in specific types of dystonia classified by body distribution and etiology. Methods: PubMed, Embase, the Cochrane Library, and Google Scholar were searched to identify studies of GPi-DBS and STN-DBS in populations with dystonia. The efficacy, quality of life, mood, and adverse effects were quantitatively compared. Meta-regression analyses were also performed. This analysis has been registered in PROSPERO under the number CRD42020146145. Results: Thirty five studies were included in the main analysis, in which 319 patients underwent GPI-DBS and 113 patients underwent STN-DBS. The average follow-up duration was 12.48 months (range, 3-49 months). The GPI and STN groups were equivalent in terms of efficacy, quality of life, mood, and occurrence of AEs. The focal group demonstrated significantly better disability symptom improvement (P = 0.012) than the segmental and generalized groups but showed less SF-36 enhancement than the segmental group (P < 0.001). The primary groups exhibited significantly better movement and disability symptom improvements than the secondary non-hereditary group (P < 0.005), which demonstrated only disability symptom improvement compared with the secondary hereditary group (P < 0.005). The primary hereditary and idiopathic groups had a significantly lower frequency of AEs than the secondary non-hereditary group (P < 0.005). The correlation between disability symptom improvement and movement symptom improvement was also significant (P < 0.05). Conclusion: GPi-DBS and STN-DBS were both safe and resulted in excellent improvement in efficacy and quality of life in patients with dystonia. Compared with patients with segmental dystonia, patients with focal dystonia demonstrated better improvement in dystonia symptoms but less enhancement of quality of life. Those with primary dystonia had a better response to DBS in terms of efficacy than those with secondary dystonia. Patients who exhibit a significant improvement in movement symptoms might also exhibit excellent improvement in disability symptoms.

Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations

Long-term outcome of pallidal stimulation for Meige syndrome.

The Efficacy And Predictors Of Using Gpi-Dbs To Treat Early-Onset Dystonia: An Individual Patient Analysis

Bilateral globus pallidus internus (GPi) deep brain stimulation for cervical dystonia: Effects on motor and non-motor symptoms within 5 years follow

Long-term Follow-Up Study of Deep Brain Stimulation for Primary Generalized Dystonia

Pallidal deep brain stimulation in the treatment of Meige syndrome

Pallidal Versus Subthalamic Deep-Brain Stimulation for Meige Syndrome: a Retrospective Study

Deep Brain Stimulation of the Globus Pallidus Internus in a Child with Refractory Dystonia due to L2-Hydroxyglutaric Aciduria

Curative effect of deep brain stimulation of different targets on myodystonia

Deep Brain Stimulation of the Globus Pallidus Internus Versus the Subthalamic Nucleus in Isolated Dystonia.

Globus Pallidus Internus Versus Subthalamic Nucleus Deep Brain Stimulation for Isolated Dystonia: A 3‐year Follow‐up

Motor outcome of dystonic camptocormia treated with pallidal neurostimulation

Deep Brain Stimulation Treating Dystonia: A Systematic Review of Targets, Body Distributions and Etiology Classifications

The long-term efficacy of deep brain stimulation for medically refractory primary generalized dystonia

Effect of pallidal deep brain stimulation on motor and non-motor functions in patients with Meige syndrome

Bilateral Globus Pallidus Interna Combined With Subthalamic Nucleus Variable Frequency Deep Brain Stimulation in the Treatment of Young-Onset Parkinson's Disease With Refractory Dyskinesia: A Case Report

Application of deep brain stimulation for the treatment of childhood-onset dystonia in patients with MEPAN syndrome

Efficacy Analysis of Deep Brain Stimulation for Primary Generalized Dystonia of Different Targets

Long-term follow-up of pallidal deep brain stimulation for craniocervical dystonia: is the globus pallidus internus the best target?

Experience of pallidal deep brain stimulation in dystonia at a tertiary care centre in India: An initial experience

Pallidal deep brain stimulation in primary Meige syndrome: clinical outcomes and psychiatric features